Description
Why It’s Done:
The CD10 IHC test is used to:
• Diagnose and classify hematologic malignancies, especially lymphomas and leukemias.
• Differentiate between tumor types, especially when the origin of cancer is uncertain.
• Identify certain types of solid tumors, such as renal cell carcinoma.
• Assist in prognosis and treatment planning, especially when combined with other IHC markers.
This test is often used alongside a panel of other markers to provide a clearer picture of the tumor’s nature.
Preparation:
• No special preparation is required from the patient.
• The test is done on a formalin-fixed, paraffin-embedded tissue sample obtained during a biopsy or surgery.
• Patients undergoing biopsy may need to follow specific instructions based on the procedure (e.g., fasting, stopping certain medications), as advised by the doctor.


